Ownership history in CAXTON CORP · 3 quarters on record
This page tracks every 13F SEC filing in which CAXTON CORP reported a position in X4 PHARMACEUTICALS INC (XFOR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 15,557 | — | 0% | 1.45% | $62K | $4.00 |
| 2013 Q1 | UNCHANGED | 15,557 | — | 0% | 1.45% | $62K | — |
| 2012 Q4 | INITIATED | 15,557 | — | — | 1.45% | $62K | — |
As of 2025 Q4 — sorted by position size